Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice

Journal of Clinical Investigation

Volumn 123, Issue 4, 2013, Pages 1571-1579

  Martel, Catherine ^a,b   Li, Wenjun ^b   Fulp, Brian ^c   Platt, Andrew M ^a   Gautier, Emmanuel L ^b   Westerterp, Marit ^d   Bittman, Robert ^e   Tall, Alan R ^d   Chen, Shu Hsia ^a   Thomas, Michael J ^c   Kreisel, Daniel ^b   Swartz, Melody A ^f   Sorci Thomas, Mary G ^c   Randolph, Gwendalyn J ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e CITY UNIVERSITY OF NEW YORK   (United States)

^f EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; UNCLASSIFIED DRUG; VASCULOTROPIN ANTIBODY; VASCULOTROPIN RECEPTOR ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA WALL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DONOR; LYMPH VESSEL; LYMPHATIC DRAINAGE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECIPIENT; REVERSE CHOLESTEROL TRANSPORT; VASCULARIZATION;

ANIMALS; AORTA, THORACIC; ATHEROSCLEROSIS; CAPILLARY PERMEABILITY; CARCINOMA, LEWIS LUNG; CHOLESTEROL; GENE EXPRESSION; KINETICS; LYMPHATIC VESSELS; MACROPHAGES; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; SINUS OF VALSALVA; SKIN; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 84875873877     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI63685     Document Type: Article

References (55)

1. Potteaux S, et al. Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/-mice during disease regression. J Clin Invest. 2011;121(5):2025-2036.
2. Spann NJ, et al. Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell. 2012;151(1):138-152.
3. Duewell P, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010;464(7293):1357-1361.
4. Hermansson A, et al. Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis. J Exp Med. 2010;207(5):1081-1093.
5. Small DM, Bond MG, Waugh D, Prack M, Sawyer JK. Physicochemical and histological changes in the arterial wall of nonhuman primates during progression and regression of atherosclerosis. J Clin Invest. 1984;73(6):1590-1605.
6. Wang X, Rader DJ. Molecular regulation of macrophage reverse cholesterol transport. Curr Opin Cardiol. 2007;22(4):368-372.
7. Temel RE, et al. Biliary sterol secretion is not required for macrophage reverse cholesterol transport. Cell Metab. 2010;12(1):96-102.
8. Temel RE, Brown JM. Biliary and nonbiliary contributions to reverse cholesterol transport. Curr Opin Lipidol. 2012;23(2):85-90.
9. Cuchel M, Rader DJ. Macrophage reverse cholesterol transport: Key to the regression of atherosclerosis? Circulation. 2006;113(21):2548-2555.
10. Hamon Y, et al. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat Cell Biol. 2000;2(7):399-406.
11. Alitalo K. The lymphatic vasculature in disease. Nat Med. 2011;17(11):1371-1380.
12. Cooke CJ, Nanjee MN, Stepanova IP, Olszewski WL, Miller NE. Variations in lipid and apolipoprotein concentrations in human leg lymph: Effects of posture and physical exercise. Atherosclerosis. 2004;173(1):39-45.
13. Nanjee MN, Cooke CJ, Olszewski WL, Miller NE. Concentrations of electrophoretic and size subclasses of apolipoprotein A-I-containing particles in human peripheral lymph. Arterioscler Thromb Vasc Biol. 2000;20(9):2148-2155.
14. Nanjee MN, Cooke CJ, Olszewski WL, Miller NE. Lipid and apolipoprotein concentrations in prenodal leg lymph of fasted humans. Associations with plasma concentrations in normal subjects, lipoprotein lipase deficiency, and LCAT deficiency. J Lipid Res. 2000;41(8):1317-1327.
15. Nanjee MN, Cooke CJ, Wong JS, Hamilton RL, Olszewski WL, Miller NE. Composition and ultrastructure of size subclasses of normal human peripheral lymph lipoproteins: Quantification of cholesterol uptake by HDL in tissue fluids. J Lipid Res. 2001;42(4):639-648.
16. Dietschy JM, Turley SD. Control of cholesterol turnover in the mouse. J Biol Chem. 2002; 277(6):3801-3804.
17. Rohrer L, Cavelier C, Fuchs S, Schluter MA, Volker W, von Eckardstein A. Binding, internalization and transport of apolipoprotein A-I by vascular endothelial cells. Biochim Biophys Acta. 2006; 1761(2):186-194.
18. Zhang Y, Zanotti I, Reilly MP, Glick JM, Rothblat GH, Rader DJ. Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo. Circulation. 2003; 108(6):661-663.
19. Wang X, et al. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J Clin Invest. 2007;117(8):2216-2224.
20. Rutkowski JM, Moya M, Johannes J, Goldman J, Swartz MA. Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9. Microvasc Res. 2006;72(3):161-171.
21. Plump AS, Scott CJ, Breslow JL. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci U S A. 1994;91(20):9607- 9611.
22. Holtta-Vuori M, et al. BODIPY-cholesterol: A new tool to visualize sterol trafficking in living cells and organisms. Traffic. 2008;9(11):1839-1849.
23. Li Z, Mintzer E, Bittman R. First synthesis of free cholesterol-BODIPY conjugates. J Org Chem. 2006; 71(4):1718-1721.
24. Saharinen P, Tammela T, Karkkainen MJ, Alitalo K. Lymphatic vasculature: Development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol. 2004;25(7):387-395.
25. Makinen T, et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med. 2001; 7(2):199-205.
26. Platt AM, et al. Normal dendritic cell mobilization to mouse lymph nodes under conditions of severe lymphatic hypoplasia. J Immunol. In press.
27. Lim HY, et al. Hypercholesterolemic mice exhibit lymphatic vessel dysfunction and degeneration. Am J Pathol. 2009;175(3):1328-1337.
28. Baluk P, et al. Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med. 2007;204(10):2349-2362.
29. Karkkainen MJ, et al. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci U S A. 2001;98(22):12677-12682.
30. Rong JX, et al. Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content. Circulation. 2001;104(20):2447-2452.
31. Reis ED, et al. Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model. Vasc Surgery. 2001;34(3):541-547.
32. Llodra J, Angeli V, Liu J, Trogan E, Fisher EA, Randolph GJ. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci U S A. 2004;101(32):11779- 11784.
33. Tsukamoto K, Smith P, Glick JM, Rader DJ. Liverdirected gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice. J Clin Invest. 1997;100(1):107-114.
34. Kubo H, et al. Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood. 2000;96(2):546-553.
35. Karpanen T, et al. Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation. Am J Pathol. 2006;169(2):708-718.
36. Tsukamoto K, Tangirala R, Chun SH, Pure E, Rader DJ. Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 1999; 19(9):2162-2170.
37. Boardman KC, Swartz MA. Interstitial flow as a guide for lymphangiogenesis. Circ Res. 2003;92(7):801-808.
38. Lemole GM. The role of lymphstasis in atherogenesis. Ann Thorac Surg. 1981;31(3):290-293.
39. Miller AJ, DeBoer A, Palmer A. The role of the lymphatic system in coronary atherosclerosis. Med Hypotheses. 1992;37(1):31-36.
40. Solti F, Lengyel E, Jellinek H, Schneider F, Juhasz-Nagy A, Kekesi V. Coronary arteriopathy after lymphatic blockade: An experimental study in dogs. Lymphology. 1994;27(4):173-180.
41. Oliver G. Lymphatic vasculature development. Nat Rev Immunol. 2004;4(1):35-45.
42. Williams KJ, Feig JE, Fisher EA. Rapid regression of atherosclerosis: Insights from the clinical and experimental literature. Nat Clin Pract Cardiovasc Med. 2008;5(2):91-102.
43. Yin N, et al. Lymphangiogenesis is required for pancreatic islet inflammation and diabetes. PLoS One. 2011;6(11):e28023.
44. Pytowski B, et al. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J Natl Cancer Inst. 2005; 97(1):14-21.
45. Rutkowski JM, Boardman KC, Swartz MA. Characterization of lymphangiogenesis in a model of adult skin regeneration. Am J Physiol Heart Circ Physiol. 2006;291(3):H1402-H1410.
46. Chung ES, Saban DR, Chauhan SK, Dana R. Regulation of blood vessel versus lymphatic vessel growth in the cornea. Invest Ophthalmol Vis Sci. 2009;50(4):1613-1618.
47. Sparrow CP, et al. Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering. Arterioscler Thromb Vasc Biol. 2001;21(1):115-121.
48. Hermanowski-Vosatka A, et al. 11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. J Exp Med. 2005;202(4):517-527.
49. Kholova I, et al. Lymphatic vasculature is increased in heart valves, ischaemic and inflamed hearts and in cholesterol-rich and calcified atherosclerotic lesions. Eur J Clin Invest. 2011;41(5):487-497.
50. Meyer G, Merval R, Tedgui A. Effects of pressure-induced stretch and convection on low-density lipoprotein and albumin uptake in the rabbit aortic wall. Circ Res. 1996;79(3):532-540.
51. Kim WS, Tarbell JM. Macromolecular transport through the deformable porous media of an artery wall. J Biomech Eng. 1994;116(2):156-163.
52. Baldwin AL, Wilson LM, Gradus-Pizlo I, Wilensky R, March K. Effect of atherosclerosis on transmural convection an arterial ultrastructure. Implications for local intravascular drug delivery. Arterioscler Thromb Vasc Biol. 1997;17(12):3365-3375.
53. Chereshnev I, et al. Mouse model of heterotopic aortic arch transplantation. J Surg Res. 2003;111(2):171-176.
54. Wilhelm AJ, et al. Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity. Arterioscler Thromb Vasc Biol. 2009; 29(6):843-849.
55. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37(8):911-917.